Yellow Fever Vaccine Market Report 2026

Yellow Fever Vaccine Market Overview

• Yellow Fever Vaccine market size has reached to $4.74 billion in 2025 • Expected to grow to $5.88 billion in 2030 at a compound annual growth rate (CAGR) of 4.3% • Growth Driver: Growth Of The Yellow Fever Vaccine Market Due To Increasing International Travel • Market Trend: Innovative T-Cell Adaptive Booster Vaccines-global-market-report" target="_blank">Vaccines Enhancing Global Yellow Fever Immunity • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Yellow Fever Vaccine Market?

The yellow fever vaccine is a live, attenuated viral vaccine used to prevent yellow fever, a serious viral infection transmitted by mosquitoes. It is typically administered as a single dose and provides long-lasting immunity, often lifelong. The vaccine is especially important for people living in or traveling to endemic areas. The main products of the yellow fever vaccine are powder and liquid. Yellow fever vaccine powder is a lyophilized (freeze-dried) form of the yellow fever vaccine, which requires reconstitution with a specific diluent before administration to provide immunity against the yellow fever virus. This involves various treatment types, such as pain management drugs and oral rehydration. This vaccine finds application in routine immunization, travelers, and others and is used by several end users, mainly hospitals, diagnostic centers, point-of-care centers, and others.

What Is The Yellow Fever Vaccine Market Growth Forecast?

The yellow fever vaccine market size is expected to see steady growth in the next few years. It will grow to $5.88 billion in 2030 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to climate-driven mosquito spread, increasing global travel, expansion of vaccination infrastructure, higher funding for disease prevention, stronger outbreak preparedness. Major trends in the forecast period include expansion of routine immunization programs, rising demand from international travelers, increased government-led vaccination campaigns, growing use of single-dose vaccines, focus on endemic disease prevention.

Global Yellow Fever Vaccine Market Segmentation

1) By Product: Powder, Liquid 2) By Application: Routine Immunization, Travelers, Other Applications 3) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users Subsegments: 1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution 2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

What Is The Driver Of The Yellow Fever Vaccine Market?

The increasing international travel is expected to propel the growth of the yellow fever vaccine market going forward. International travel refers to the movement of individuals across country borders for tourism, business, or personal purposes. International travel is rising due to growing global mobility supported by economic recovery and easing post-pandemic travel restrictions. The yellow fever vaccine market supports travelers by providing mandatory or recommended immunization for entry into regions where yellow fever is endemic. For instance, in January 2024, according to the World Tourism Organization (UNWTO), a Spain-based international tourism agency, global international tourist arrivals reached 1.286 billion in 2023, up from 0.96 billion in 2022, an increase of 0.326 billion international tourists year-on-year. Therefore, increasing international travel is driving the growth of the yellow fever vaccine industry.

Key Players In The Global Yellow Fever Vaccine Market

Major companies operating in the yellow fever vaccine market are Sanofi S.A., Bio-Manguinhos, Institut Pasteur de Dakar, Instituto Butantan, Bio Farma, Biological E. Limited, Beijing Tiantan Biological Products Co. Ltd., Wuhan Institute of Biological Products, Merck & Co. Inc., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Lonza Group AG, WuXi Biologics, Ology Bioservices, Valneva SE, Bavarian Nordic A/S, Panacea Biotec Ltd., Biovac, Novavax Inc., PnuVax Incorporated

Global Yellow Fever Vaccine Market Trends and Insights

Major companies operating in the yellow fever vaccine market are increasingly focusing on developing innovative solutions, such as T-cell adaptive booster vaccines, to enhance long-term immunity, improve vaccine efficacy, and address limitations of traditional live-attenuated vaccines. T-cell adaptive booster vaccines are vaccines designed to strengthen the immune system by specifically enhancing T-cell responses, which help the body recognize and fight infections more effectively compared to traditional antibody-focused vaccines. For instance, in April 2025, the All India Institute of Medical Sciences, an India-based healthcare institute, launched Yellow Fever Vaccination to provide travelers with protection against the mosquito-borne viral disease and issue the internationally recognized vaccination certificate. The initiative aims to increase accessibility to the vaccine within Telangana, reducing the need for long-distance travel to other authorized centers. Additionally, the program ensures adherence to international health regulations by offering safe administration under medical supervision, particularly for individuals with contraindications.

What Are Latest Mergers And Acquisitions In The Yellow Fever Vaccine Market?

In November 2025, Mabloc, LLC, a US-based biotechnology company, partnered with Instituto Butantan to advance a first-in-class monoclonal antibody therapy for the treatment and prevention of yellow fever. This partnership aims to develop a safe and effective post-exposure and preventive therapy for yellow fever, addressing the unmet medical need for disease-specific treatment. Instituto Butantan is a Brazil-based public research center and vaccine manufacturer.

Regional Insights

North America was the largest region in the yellow fever vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Yellow Fever Vaccine Market?

The yellow fever vaccine market consists of sales of vaccine syringes, needles, and vaccine storage equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Yellow Fever Vaccine Market Report 2026?

The yellow fever vaccine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the yellow fever vaccine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.